Cancell/Cantron/Protocel (PDQ®)–Versión para pacientes
Resumen de información revisada por expertos sobre el uso de Cancell/Entelev como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1087831.htm
- Syndication ID: 19376
- Language: Spanish
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:13 PM
- Date Syndication Updated: Thursday, July 01, 2021 at 06:06 AM
Tags
General:
Cancell
childhood liver cancer
Childhood hepatoblastoma
Childhood hepatocellular carcinoma
Childhood undifferentiated embryonal sarcoma of the liver
Infantile choriocarcinoma of the liver
Childhood epithelioid hemangioendothelioma
Embed Code Snippet
To get the embed code snippet please Login.
